Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-27 Sale |
2020-12-01 7:45 pm |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
43,282 | $4.4058 | $190,694 | 1,213,298 (Direct) |
View |
| 2020-11-23 Sale |
2020-11-25 7:51 pm |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
30,431 | $4.2973 | $130,770 | 1,338,279 (Direct) |
View |
| 2020-11-06 Purchase |
2020-11-10 4:25 pm |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer 10% Owner |
14,071,856 | $3.34 | $46,999,999 | 56,296,533 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-02-19 Option Award |
2021-02-23 6:04 pm |
2021-12-31 2031-02-19 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Director |
25,000 | $0 | 252,273 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 6:01 pm |
2021-12-31 2031-02-19 |
Summit Therapeutics Inc. | SMMT | Erdtmann Rainer M Director |
25,000 | $0 | 252,273 (Direct) |
View |
| 2021-02-19 Option Award |
2021-02-23 5:55 pm |
2021-12-31 2031-02-19 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
25,000 | $0 | 238,340 (Direct) |
View |
| 2020-11-27 Exercise |
2020-12-01 7:45 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
16,616 | $1.92 | 1,213,298 (Direct) |
View |
| 2020-11-27 Exercise |
2020-12-01 7:45 pm |
N/A 2029-03-29 |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
26,666 | $1.79 | 1,213,298 (Direct) |
View |
| 2020-11-27 Exercise |
2020-12-01 7:45 pm |
N/A 2028-10-19 |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
16,616 | $1.92 | 1,213,298 (Direct) |
View |
| 2020-11-27 Exercise |
2020-12-01 7:45 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
26,666 | $1.79 | 1,213,298 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 7:51 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
30,431 | $1.92 | 1,338,279 (Direct) |
View |
| 2020-11-23 Exercise |
2020-11-25 7:51 pm |
N/A 2028-10-19 |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
30,431 | $1.92 | 1,338,279 (Direct) |
View |
| 2020-11-22 Option Award |
2020-11-24 6:12 pm |
2021-11-22 2030-11-22 |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Chief Operating Officer |
2,400,000 | $0 | 8,083,282 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-13 5:25 pm |
2021-11-11 2030-11-11 |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Director |
203,323 | $0 | 7,004,460 (Direct) |
View |
Ownership |
2020-11-13 5:20 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Zanganeh Maky Director |
0 | $0 | 5,479,960 (Indirect) |
View |
| 2020-10-04 Option Award |
2020-10-07 7:47 pm |
N/A 2030-10-04 |
Summit Therapeutics Inc. | SMMT | Graham Camilla Chief Clinical Affairs Officer |
400,000 | $3.34 | 400,000 (Direct) |
View |
| 2020-10-02 Option Award |
2020-10-06 7:42 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W Chief Executive Officer 10% Owner |
9,730,539 | $0 | 51,955,216 (Direct) |
View |
Ownership |
2020-09-18 4:17 pm |
N/A 2030-05-01 |
Summit Therapeutics Inc. | SMMT | Erdtmann Rainer M Director |
0 | $0 | 227,273 (Direct) |
View |
Ownership |
2020-09-18 4:17 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | DUGGAN ROBERT W See Remarks 10% Owner |
0 | $0 | 46,209,732 (Direct) |
View |
Ownership |
2020-09-18 4:17 pm |
N/A 2029-12-23 |
Summit Therapeutics Inc. | SMMT | Soni Manmeet Singh Director |
0 | $0 | 227,273 (Direct) |
View |
Ownership |
2020-09-18 4:16 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Houbiers Jos Chief Medical Officer |
0 | $0 | 416,800 (Direct) |
View |
Ownership |
2020-09-18 4:14 pm |
N/A 2030-06-08 |
Summit Therapeutics Inc. | SMMT | Donaldson Michael Paul Chief Financial Officer |
0 | $0 | 600,000 (Direct) |
View |
Ownership |
2020-09-18 4:14 pm |
N/A 2030-07-13 |
Summit Therapeutics Inc. | SMMT | Mahatme Ujwala Director |
0 | $0 | 213,340 (Direct) |
View |
Ownership |
2020-09-18 4:14 pm |
N/A 2028-10-19 |
Summit Therapeutics Inc. | SMMT | Powell David Jonathan Chief Scientific Officer |
0 | $0 | 464,686 (Direct) |
View |
Ownership |
2020-09-18 4:13 pm |
N/A N/A |
Summit Therapeutics Inc. | SMMT | Stefanov Ventzislav See Remarks |
0 | $0 | 1,442,173 (Direct) |
View |